Publications

Linden announces minority investment from Blue Owl’s GP Strategic Capital Platform and Lunate
Other - MAY 28, 2024

To read this full article you need to be subscribed to Newsline.

Sign in Sign up for a FREE subscription

Linden announces minority investment from Blue Owl’s GP Strategic Capital Platform and Lunate

by Released

Linden Capital Partners, a Chicago-based healthcare private equity firm, has received a minority investment from Blue Owl’s GP Strategic Capital platform and Lunate Capital via their joint venture. Terms of the transaction were not disclosed.

Founded in 2004, Linden Capital Partners has grown to become one of the largest dedicated healthcare private equity firms in the United States, through a model of partnership with management teams and a rigorous Value Creation Program. Linden has approximately $8.0 billion of regulatory assets under management and has invested in more than 45 healthcare companies across more than 350 transactions. Linden invests in middle market platforms in the targeted subsectors of healthcare services, medical products, and specialty distribution.

Blue Owl’s GP Strategic Capital platform provides minority equity and financing solutions to private capital managers. The platform has $55.8 billion of assets under management and has completed m

Forgot your username or password?